Page last updated: 2024-08-21

ethambutol and Co-infection

ethambutol has been researched along with Co-infection in 24 studies

Research

Studies (24)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	23 (95.83)	24.3611
2020's	1 (4.17)	2.80

Authors

Authors	Studies
Äbelö, A; Ashton, M; Bienvenu, E; Birgersson, S; Sundell, J	1
Chirehwa, MT; Denti, P; McIlleron, H; Mthiyane, T; Onyebujoh, P; Rustomjee, R; Smith, P	2
Buzibye, A; Castelnuovo, B; Corti, N; Fehr, J; Gutteck, U; Henning, L; Kambugu, A; Lamorde, M; Ledergerber, B; Muller, D; Musaazi, J; Sekaggya-Wiltshire, C; von Braun, A	1
Ameni, G; Medihn, G; Mersha, W; Tamirat, M; Teklu, T; Wondale, B	1
Adane, K; Dinant, GJ; Spigt, M	1
Boulle, A; Fox, T; Khomo, N; Kock, Y; Leslie, J; Manning, K; Meintjes, G; Mudaly, V; Stewart, A; Tiffin, N; Wasserman, S; Zhao, Y	1
Bang, H; Delva, S; Joissaint, G; Koenig, SP; Pape, JW; Peeples, M; Pry, J; Royal, G; Souroutzidis, A; Vilbrun, SC; Walsh, KF; Widmann, P	1
Basso, EA; Gauze, GF; Kioshima, ÉS; Rodrigues, FA; Rozada, AM; Sampiron, EG; Scodro, RB; Seixas, FA	1
Bisson, GP; Gumbo, T; Ivaturi, V; Mehta, K; Modongo, C; Pasipanodya, JG; Ravimohan, S; Srivastava, S; Vinnard, C; Weissman, D; Zetola, NM	1
Horsburgh, CR; Kvasnovsky, C; Master, I; O'Donnell, MR; Padayatchi, N; Werner, L	1
Bremang, S; Casey, R; Connell, D; Evans, JT; Hawkey, PM; Hingley-Wilson, SM; Jepson, A; Kon, OM; Lalvani, A; Philip, S; Smith, GE	1
Camara, C; Furtado, A; Gerstoft, J; Katzenstein, TL; Lüneborg-Nielsen, M; Sodemann, M; Wejse, C	1
Berhan, A; Berhan, Y; Yizengaw, D	1
Bateson, AL; Butcher, PD; Charalambous, S; Churchyard, GJ; Clouting, HE; Coleman, D; Geldenhuys, H; Harrison, TS; Hatherill, M; Jindani, A; Magweta, L; McHugh, TD; McIlleron, HM; Mitchison, DA; Mungofa, S; Nunn, AJ; Nyirenda, S; Phillips, PP; Shah, NA; Shepherd, J; van Dijk, JH; Zizhou, S; Zvada, SP	1
Alobu, I; Oshi, DC; Oshi, SN; Ukwaja, KN	1
Garcia-Rodriguez, F; Martinez-Longoria, CA; Rios-Solis, JE; Rubio-Perez, NE	1
Eckold, C; Evangelopoulos, D; Gillespie, SH; Honeyborne, I; Lipman, MC; McHugh, TD; Pym, A	1
Acuña-Villaorduña, C; Ayakaka, I; Dryden-Peterson, S; Fennelly, KP; Hosford, J; Jones-López, EC; Nakubulwa, S; Okwera, A; Reilly, N; Worodria, W	1
Egan, D; Hennig, S; Kellerman, T; McIlleron, H; Naiker, S; Owen, A; Pym, A; Reddy, T; Wiesner, L	1
Bekker, A; Donald, PR; Draper, HR; Hesseling, AC; McIlleron, HM; Murray, S; Schaaf, HS; van der Laan, L; Wiesner, L	1
Kabra, SK; Kanhiya, K; Lodha, R; Mukherjee, A; Singla, M; Velpandian, T	1
Abdissa, A; Abdissa, K; Abebe, G; Agonafir, M; Apers, L; Colebunders, R; de-Jong, BC	1
Hesseling, AC; Jordaan, A; Marais, BJ; Schaaf, HS; Seddon, JA; Victor, T	1

Reviews

1 review(s) available for ethambutol and Co-infection

Article	Year
A meta-analysis of drug resistant tuberculosis in Sub-Saharan Africa: how strongly associated with previous treatment and HIV co-infection? Ethiopian journal of health sciences, 2013, Volume: 23, Issue:3 Topics: Adolescent; Adult; Africa South of the Sahara; Aged; Aged, 80 and over; Antitubercular Agents; Child; Coinfection; Ethambutol; Female; HIV Infections; Humans; Male; Middle Aged; Prevalence; Rifampin; Tuberculosis, Multidrug-Resistant; Young Adult	2013

Article

Year

A meta-analysis of drug resistant tuberculosis in Sub-Saharan Africa: how strongly associated with previous treatment and HIV co-infection?

Ethiopian journal of health sciences, 2013, Volume: 23, Issue:3

Topics: Adolescent; Adult; Africa South of the Sahara; Aged; Aged, 80 and over; Antitubercular Agents; Child; Coinfection; Ethambutol; Female; HIV Infections; Humans; Male; Middle Aged; Prevalence; Rifampin; Tuberculosis, Multidrug-Resistant; Young Adult

2013

Trials

4 trial(s) available for ethambutol and Co-infection

Article	Year
Impact of tuberculosis treatment on CD4 cell count, HIV RNA, and p24 antigen in patients with HIV and tuberculosis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2013, Volume: 17, Issue:10 Topics: Adult; Antitubercular Agents; Biomarkers; CD4 Lymphocyte Count; Coinfection; Dietary Supplements; Drug Therapy, Combination; Ethambutol; Female; Guinea-Bissau; HIV Core Protein p24; HIV Infections; HIV-1; HIV-2; Humans; Isoniazid; Kaplan-Meier Estimate; Male; Middle Aged; Pyrazinamide; Rifampin; RNA, Viral; Tuberculosis, Pulmonary; Vitamin D; Young Adult	2013
High-dose rifapentine with moxifloxacin for pulmonary tuberculosis. The New England journal of medicine, 2014, Oct-23, Volume: 371, Issue:17 Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; HIV Seropositivity; Humans; Isoniazid; Kaplan-Meier Estimate; Male; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Young Adult	2014
Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Adult; Antitubercular Agents; Area Under Curve; CD4 Lymphocyte Count; Coinfection; Ethambutol; Female; Gene Expression; HIV Infections; Humans; Isoniazid; Liver-Specific Organic Anion Transporter 1; Male; Monte Carlo Method; Organic Anion Transporters; Polymorphism, Single Nucleotide; Pyrazinamide; Rifabutin; Rifampin; Sex Factors; Tuberculosis, Pulmonary	2016
Pharmacokinetics of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol in Infants Dosed According to Revised WHO-Recommended Treatment Guidelines. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:4 Topics: Anti-Bacterial Agents; Area Under Curve; Coinfection; Drug Dosage Calculations; Ethambutol; Female; HIV; HIV Infections; Humans; Infant; Infant, Newborn; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary	2016

Other Studies

19 other study(ies) available for ethambutol and Co-infection

Article	Year
Population Pharmacokinetics and Pharmacogenetics of Ethambutol in Adult Patients Coinfected with Tuberculosis and HIV. Antimicrobial agents and chemotherapy, 2020, 01-27, Volume: 64, Issue:2 Topics: Administration, Oral; Adult; Antitubercular Agents; Biological Availability; Body Weight; Coinfection; Cytochrome P-450 CYP1A2; Ethambutol; Female; Genotype; HIV Infections; Humans; Male; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Rwanda; Tuberculosis, Pulmonary	2020
Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant Tuberculosis. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:8 Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Drug Combinations; Ethambutol; HIV Infections; Humans; Isoniazid; Male; Metabolic Clearance Rate; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult	2017
Cohort profile of a study on outcomes related to tuberculosis and antiretroviral drug concentrations in Uganda: design, methods and patient characteristics of the SOUTH study. BMJ open, 2017, 09-18, Volume: 7, Issue:9 Topics: Adult; Anti-Retroviral Agents; Antitubercular Agents; Biomedical Research; CD4 Lymphocyte Count; Cohort Studies; Coinfection; Drug Combinations; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Pyrazinamide; Research Design; Rifampin; Tuberculosis, Pulmonary; Uganda	2017
A retrospective study on tuberculosis treatment outcomes at Jinka General Hospital, southern Ethiopia. BMC research notes, 2017, Dec-04, Volume: 10, Issue:1 Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Drug Combinations; Ethambutol; Ethiopia; Female; HIV Infections; Hospitals, General; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Sex Factors; Streptomycin; Survival Analysis; Treatment Outcome; Tuberculosis, Pulmonary	2017
Tuberculosis treatment outcome and predictors in northern Ethiopian prisons: a five-year retrospective analysis. BMC pulmonary medicine, 2018, Feb-20, Volume: 18, Issue:1 Topics: Adolescent; Adult; Aftercare; Anti-Retroviral Agents; Antitubercular Agents; Coinfection; Directly Observed Therapy; Drug Therapy, Combination; Ethambutol; Ethiopia; Female; HIV Infections; Humans; Isoniazid; Logistic Models; Lost to Follow-Up; Male; Multivariate Analysis; Patient Discharge; Patient Transfer; Prisoners; Prisons; Pyrazinamide; Retreatment; Retrospective Studies; Rifampin; Risk Factors; Sputum; Streptomycin; Treatment Failure; Treatment Outcome; Tuberculosis; Tuberculosis, Pulmonary; Young Adult	2018
Improved Treatment Outcomes With Bedaquiline When Substituted for Second-line Injectable Agents in Multidrug-resistant Tuberculosis: A Retrospective Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 04-24, Volume: 68, Issue:9 Topics: Adult; Antitubercular Agents; Coinfection; Diarylquinolines; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Female; HIV; HIV Infections; Humans; Isoniazid; Isoxazoles; Levofloxacin; Male; Mycobacterium tuberculosis; Oxazolidinones; Pyrazinamide; Retrospective Studies; South Africa; Survival Analysis; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2019
Potentially High Number of Ineffective Drugs with the Standard Shorter Course Regimen for Multidrug-Resistant Tuberculosis Treatment in Haiti. The American journal of tropical medicine and hygiene, 2019, Volume: 100, Issue:2 Topics: Adult; Antitubercular Agents; Coinfection; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Female; Fluoroquinolones; Haiti; HIV; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2019
Novel 4-methoxynaphthalene- Future microbiology, 2019, Volume: 14 Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Coinfection; Drug Combinations; Drug Discovery; Drug Synergism; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Paracoccidioides; Paracoccidioidomycosis; Tuberculosis	2019
Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study. The Journal of antimicrobial chemotherapy, 2019, 10-01, Volume: 74, Issue:10 Topics: Adult; Antitubercular Agents; Biological Availability; Botswana; Coinfection; Ethambutol; Female; HIV Infections; Humans; Male; Middle Aged; Prospective Studies; Tuberculosis, Pulmonary	2019
Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection. Emerging infectious diseases, 2013, Volume: 19, Issue:3 Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Cycloserine; Drug Therapy, Combination; Ethambutol; Ethionamide; Extensively Drug-Resistant Tuberculosis; Female; HIV Infections; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult	2013
Undetected multidrug-resistant tuberculosis amplified by first-line therapy in mixed infection. Emerging infectious diseases, 2013, Volume: 19, Issue:7 Topics: Aged; Antitubercular Agents; Coinfection; Culture Techniques; Delayed Diagnosis; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Minisatellite Repeats; Molecular Diagnostic Techniques; Multilocus Sequence Typing; Mycobacterium tuberculosis; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2013
Investigating gender disparities in the profile and treatment outcomes of tuberculosis in Ebonyi state, Nigeria. Epidemiology and infection, 2015, Volume: 143, Issue:5 Topics: Adult; Antitubercular Agents; Cohort Studies; Coinfection; Ethambutol; Female; Health Status Disparities; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Nigeria; Pyrazinamide; Retrospective Studies; Rifampin; Rural Population; Sex Factors; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis; Tuberculosis, Pulmonary; Urban Population; Young Adult	2015
Severe meningoencephalitis co-infection due to Cryptococcus neoformans and Mycobacterium tuberculosis in a child with systemic lupus erythematosus. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2015, Volume: 33 Topics: Amphotericin B; Antitubercular Agents; Child; Coinfection; Cryptococcosis; Cryptococcus neoformans; Ethambutol; Female; Humans; Immunocompromised Host; Isoniazid; Lupus Erythematosus, Systemic; Meningoencephalitis; Mycobacterium tuberculosis; Pyrazinamide; Rifampin	2015
Effective anti-tuberculosis therapy correlates with plasma small RNA. The European respiratory journal, 2015, Volume: 45, Issue:6 Topics: Adult; Antitubercular Agents; Biomarkers; Coinfection; Ethambutol; Female; Gene Expression Profiling; HIV Infections; Humans; Isoniazid; Male; MicroRNAs; Prospective Studies; Pyrazinamide; Rifampin; RNA; Treatment Outcome; Tuberculosis, Pulmonary	2015
High mortality associated with retreatment of tuberculosis in a clinic in Kampala, Uganda: a retrospective study. The American journal of tropical medicine and hygiene, 2015, Volume: 93, Issue:1 Topics: Adult; Antitubercular Agents; Coinfection; Ethambutol; Female; Follow-Up Studies; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Proportional Hazards Models; Pyrazinamide; Recurrence; Retreatment; Retrospective Studies; Rifampin; Streptomycin; Survival Rate; Treatment Failure; Treatment Outcome; Tuberculosis; Uganda	2015
Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Area Under Curve; Biological Availability; Biotransformation; Body Weight; Clinical Trials as Topic; Cohort Studies; Coinfection; Computer Simulation; Ethambutol; Female; Half-Life; HIV Infections; Humans; Isoniazid; Liver; Male; Middle Aged; Models, Statistical; Rifampin; Tuberculosis, Pulmonary	2016
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2016, Volume: 20, Issue:5 Topics: Adolescent; Age Factors; Antitubercular Agents; Child; Child, Preschool; Chromatography, Liquid; Coinfection; Drug Dosage Calculations; Drug Monitoring; Ethambutol; Female; HIV Infections; Humans; India; Infant; Isoniazid; Male; Prospective Studies; Pyrazinamide; Rifampin; Spectrometry, Mass, Electrospray Ionization; Treatment Outcome; Tuberculosis	2016
Relatively low primary drug resistant tuberculosis in southwestern Ethiopia. BMC research notes, 2012, May-10, Volume: 5 Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethiopia; Female; HIV Infections; Humans; Isoniazid; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Odds Ratio; Prevalence; Rifampin; Risk Assessment; Risk Factors; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult	2012
The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2012, Volume: 16, Issue:7 Topics: Adolescent; AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Child, Preschool; Coinfection; Epidemics; Ethambutol; Female; HIV Infections; Humans; Infant; Infant, Newborn; Isoniazid; Male; Mycobacterium tuberculosis; Prevalence; Rifampin; South Africa; Tuberculosis, Multidrug-Resistant	2012